Walleye Capital
MDLN

Walleye Capital’s Medline Inc MDLN Stock Holding History

Walleye Capital’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$349K Sell
8,848
-396,425
-98% -$16M ﹤0.01% 3050
2026
Q1 		$18M Hold
405,273
– – 0.08% 229
2025
Q4 		$17M Buy
+405,273
New +$17.1M 0.05% 365

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Walleye Capital's MDLN Position: Q2 2026 in Review

Walleye Capital reduced its Medline Inc (MDLN) stake by 98% in Q2 2026, selling an estimated $16M and leaving 8,848 shares worth $349K. The position accounts for ﹤0.01% of the portfolio, ranked #3050.

Walleye Capital first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $18M in Q1 2026. 407 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Walleye Capital held 8,848 shares of Medline Inc worth $349K as of Q2 2026.
  • Walleye Capital sold 396,425 Medline Inc shares in Q2 2026, an estimated $16M.
  • Medline Inc made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3050 holding.
  • Walleye Capital first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • Walleye Capital's Medline Inc position peaked at $18M in Q1 2026.
  • 407 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.